Cargando…

STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway

Tumor metastasis is a leading cause of death in lung adenocarcinoma (LUAD) patients, but the molecular events that regulate metastasis have not been completely elucidated. STAMBP is a deubiquitinating enzyme of the Jab1/MPN metalloenzyme family that regulates the stability of substrates in cells by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hui, Yang, Xiaomei, Xuan, Xiaofeng, Wu, Di, Zhang, Jieru, Xu, Xinchun, Zhao, Yuanjie, Ma, Chunping, Li, Dawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190130/ https://www.ncbi.nlm.nih.gov/pubmed/34102455 http://dx.doi.org/10.1016/j.neo.2021.05.011

Ejemplares similares

Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
por: Zhang, Jieru, et al.
Publicado: (2020)

PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway
por: Xu, Xinchun, et al.
Publicado: (2021)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity
por: Bednash, Joseph S., et al.
Publicado: (2017)

Novel compound heterozygous mutation in STAMBP causes a neurodevelopmental disorder by disrupting cortical proliferation
por: Hu, Meixin, et al.
Publicado: (2022)

Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway
por: Li, Min, et al.
Publicado: (2023)

Mutations in STAMBP, encoding a deubiquitinating enzyme, cause Microcephaly-Capillary Malformation syndrome
por: McDonell, Laura M., et al.
Publicado: (2013)

Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
por: Guo, Yusong, et al.
Publicado: (2021)

XBP1s promotes the development of lung adenocarcinoma via the p-JNK MAPK pathway
por: Jiang, Hongxia, et al.
Publicado: (2022)

Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma
por: Nie, Yunqiang, et al.
Publicado: (2017)

Early-onset epilepsy and microcephaly-capillary malformation syndrome caused by a novel STAMBP mutation in a Chinese boy
por: Wu, Fangrui, et al.
Publicado: (2019)

Novel STAMBP mutations in a Chinese girl with rare symptoms of microcephaly-capillary malformation syndrome and Mowat-Wilson syndrome
por: Wang, Hui, et al.
Publicado: (2023)

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway
por: Zhang, Xiaojian, et al.
Publicado: (2016)

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report
por: Dansin, Eric, et al.
Publicado: (2015)

Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma
por: Guo, Haisheng, et al.
Publicado: (2016)

Prognostic Factors in Lung Adenocarcinoma with Bone Metastasis Treated with EGFR-TKIs
por: Chiu, Tzu-Hsuan, et al.
Publicado: (2021)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway
por: Zhang, Hong, et al.
Publicado: (2022)

FOXM1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Upregulating SNAIL
por: Wei, Ping, et al.
Publicado: (2015)

-216G/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma
por: GUO, HAISHENG, et al.
Publicado: (2013)

Aldolase A promotes proliferation and G(1)/S transition via the EGFR/MAPK pathway in non-small cell lung cancer
por: Fu, Hailu, et al.
Publicado: (2018)

RNF128 Promotes Invasion and Metastasis Via the EGFR/MAPK/MMP-2 Pathway in Esophageal Squamous Cell Carcinoma
por: Gao, Jing, et al.
Publicado: (2019)

Hypoxia Activates Notch4 via ERK/JNK/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis
por: Li, Xiaochen, et al.
Publicado: (2021)

Detected EGFR mutation in cerebrospinal fluid of lung adenocarcinoma patients with meningeal metastasis
por: Rong, Jiang, et al.
Publicado: (2016)

The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability
por: Yang, Qianqian, et al.
Publicado: (2022)

Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway
por: Yang, Mengdi, et al.
Publicado: (2020)

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021)

CHAC2 promotes lung adenocarcinoma by regulating ROS-mediated MAPK pathway activation
por: Peng, Weilin, et al.
Publicado: (2023)

KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
por: Xu, Hui, et al.
Publicado: (2020)

SPC24 promotes osteosarcoma progression by increasing EGFR/MAPK signaling
por: Sheng, Jun, et al.
Publicado: (2017)

CBX2 and EZH2 cooperatively promote the growth and metastasis of lung adenocarcinoma
por: Hu, Fei-Fei, et al.
Publicado: (2021)

SHC1 Promotes Lung Cancer Metastasis by Interacting with EGFR
por: Yang, Pan, et al.
Publicado: (2022)

Next‐generation sequencing assisted diagnosis of cervical metastasis in EGFR‐mutated lung adenocarcinoma: A case report
por: Xu, Li, et al.
Publicado: (2021)

Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique
por: Gu, Yangchun, et al.
Publicado: (2021)

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
por: Liang, Naixin, et al.
Publicado: (2022)

Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
por: Ye, Chenyang, et al.
Publicado: (2016)

Female genital tract metastasis of lung adenocarcinoma with EGFR mutations: Report of two cases
por: Yan, Run-Lan, et al.
Publicado: (2019)

Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report
por: Cao, Liyu, et al.
Publicado: (2020)

Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
por: Ma, Xiaoyan, et al.
Publicado: (2016)

IQGAP3 Promotes EGFR-ERK Signaling and the Growth and Metastasis of Lung Cancer Cells
por: Yang, Ying, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_76qc31lk4b1sfnk3r424q1mql7